The new era of add-on asthma treatments: where do we stand?

HIGHLIGHTS

• who: William J. Calhoun from the ACTu200bAsthma Control Test, ACQ Asthma Control Questionnaire, AE adverse event, AQLQ Asthma Quality of Life Questionnaire, FDA Food and Drug Administration, FEF25-75% forced expiratory flow between , and, % of FVC, forced expiratory volume in , s, FEV1(0, h) forced expiratory volume within , h after dosing, FVC forced vital capacity, IGETE Investigator`s Global Evaluation of Treatment Effectiveness, IgE immunoglobulin E, IL interleukin, IV intravenous, SC subcutaneous, Q W once every , weeks, Q W once every , weeks, Q W once every , weeks, SGRQ StGeorge`s Respiratory Questionnaire, Th T helper, TSLP thymic . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.